Posaconazole Powder
NDC Package 76397-024-08
Package Information
Posaconazole powders is posaconazole is used to prevent certain fungal infections in patients who have severely weakened immune systems (such as patients who have had chemotherapy). This formulation utilizes a powder delivery system. Marketed by Zhejiang Ausun Pharmaceutical Co., Ltd., this product is identified by NDC 76397-024.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 76397 - Zhejiang Ausun Pharmaceutical Co., Ltd.
- 76397-024 -
- 76397-024-08 - 100 g in 1 BAG
- 76397-024 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (76397-024). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76397-024-08 identifies a specific commercial package of 100 g in 1 bag of Posaconazole (UNFINISHED drug), a bulk ingredient labeled by Zhejiang Ausun Pharmaceutical Co., Ltd.. This powder is formulated for use and contains posaconazole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zhejiang Ausun Pharmaceutical Co., Ltd. on January 01, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Posaconazole is used to prevent certain fungal infections in patients who have severely weakened immune systems (such as patients who have had chemotherapy). It belongs to a class of drugs known as azole antifungals. It works by stopping the growth of fungi.
How is this Zhejiang Ausun Pharmaceutical Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76397002408. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.